If you searched for “myalgia rheumatica,” the condition usually meant is polymyalgia rheumatica (PMR). It often causes new pain and stiffness around both shoulders and the hips, especially in the morning, in people over 50. Raised inflammation markers can support the diagnosis, but they cannot confirm it on their own. Clinicians also look for other causes and watch for signs of giant cell arteritis (GCA), which needs urgent assessment.
What “myalgia rheumatica” usually means
PMR commonly begins over days or weeks. Morning stiffness may last more than 45 minutes, and pain can make it hard to raise your arms, get dressed, turn in bed or rise from a chair. Neck discomfort, fatigue and feeling generally unwell can also occur. The pattern matters: pain limited to one joint, or symptoms that develop gradually over a long period, may point toward another explanation.
PMR is rare under age 50. There is no single test that establishes the diagnosis, and classification criteria developed for research are not a substitute for clinical assessment. Your clinician considers your symptoms and examination together with test results and whether another condition better explains the picture.
How PMR blood tests help—and where they fall short
Blood tests usually include C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which measure inflammation. They are often raised in PMR, so high results alongside the typical symptoms make the diagnosis more plausible. But infection and other inflammatory illnesses can also raise them. Normal results make PMR less typical, yet do not rule it out in every case.
Before treatment, clinicians may also check a blood count, kidney and liver function, thyroid tests and creatine kinase (CK), depending on your situation. These checks can help identify other explanations or provide a baseline for monitoring. Rheumatoid factor and anti-CCP antibodies may be considered when joint symptoms suggest rheumatoid arthritis (RA).
Distinguishing PMR from look-alike conditions
RA can cause stiffness and pain, but persistent swelling or inflammation in the smaller joints of the hands and feet may point away from straightforward PMR. Some people initially thought to have PMR are later found to have RA, so ongoing or changing symptoms deserve review rather than an assumption that the original diagnosis still fits.
Medication-related muscle symptoms are another possibility. Tell your clinician about all medicines you take, including statins; the timing of symptoms and, when appropriate, a CK test can help guide assessment. Thyroid problems, muscle disease, joint or tendon conditions, infection and other illnesses can also resemble PMR. A quick improvement with steroids may support PMR, but it does not prove it: steroids can ease inflammation from other causes and may temporarily mask symptoms.
Polymyalgia rheumatica treatment and follow-up
Doctors commonly treat PMR with a moderate dose of an oral glucocorticoid such as prednisone or prednisolone. Guidance often places an initial dose in the range of 12.5–25 mg daily, but the appropriate dose depends on the person and the clinical picture. Names and local prescribing guidance vary by country.
Symptoms often improve quickly with appropriate treatment, but that response is only one part of the assessment. The dose is usually reduced gradually over time, guided by symptoms, blood tests and side effects. Treatment may last a year or longer, and reducing too quickly or stopping without a plan can be unsafe. Do not change your dose on your own.
Relapses are common: Norwegian Society of Rheumatology recommendations, published in 2024, cite an estimate that about 43% of patients have at least one relapse within a year of starting glucocorticoids. At follow-up, tell your clinician if shoulder or hip stiffness returns, daily activities become harder, or new symptoms appear. Persistent inflammation markers without symptoms should also be interpreted by a clinician rather than prompting an automatic dose increase.
Longer-term steroids can affect bone health. Ask how your fracture risk will be assessed and whether you need a bone-protection plan. Regular review also gives you a chance to discuss other possible steroid side effects and whether specialist input or a steroid-sparing medicine is appropriate.
When symptoms could signal giant cell arteritis
PMR can occur alongside GCA, an inflammation of blood vessels that can threaten vision. Get urgent medical assessment for a new headache, scalp tenderness, pain or fatigue in your jaw while chewing, or blurred, double or lost vision. Do not wait for a routine PMR appointment if these symptoms appear. For more detail, read about giant cell arteritis warning signs.
If your symptoms are new and affecting your movement, arrange a clinical assessment rather than trying to diagnose PMR from a blood test or a response to steroids. A clinician can weigh the pattern, check for mimics and decide what follow-up is needed.
